EZZ Life Science Holdings Limited
ASX:EZZ.AX
3.5 (AUD) • At close October 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 44.747 | 21.697 | 10.848 | 22.018 | 11.017 | 15.126 | 7.563 | 8.808 | 4.404 | 6.214 | 3.107 | 9.723 | 4.861 | 12.565 | 6.282 | 8.248 | 4.451 | 9.067 | 4.534 |
Cost of Revenue
| 10.013 | 7.14 | 3.194 | 5.336 | 2.32 | 4.605 | 1.986 | 4.829 | 2.144 | 3.699 | 1.613 | 5.009 | 2.284 | 5.627 | 2.63 | 6.444 | 3.095 | 7.31 | 3.549 |
Gross Profit
| 34.734 | 14.557 | 7.654 | 16.682 | 8.697 | 10.521 | 5.577 | 3.979 | 2.26 | 2.515 | 1.494 | 4.713 | 2.577 | 6.938 | 3.652 | 1.804 | 1.356 | 1.758 | 0.984 |
Gross Profit Ratio
| 0.776 | 0.671 | 0.706 | 0.758 | 0.789 | 0.696 | 0.737 | 0.452 | 0.513 | 0.405 | 0.481 | 0.485 | 0.53 | 0.552 | 0.581 | 0.219 | 0.305 | 0.194 | 0.217 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0.059 | 0.059 | 0.049 | 0.049 | 0.071 | 0.071 | 0.06 | 0.06 | 0.079 | 0.079 | 0.068 | 0.068 | 0.01 | 0.01 | 0.074 | 0.074 | 0.074 | 0.074 |
Selling & Marketing Expenses
| 0 | 5.867 | 5.867 | 6.399 | 6.399 | 3.88 | 3.88 | 0.864 | 0.864 | 0.621 | 0.621 | 1.585 | 1.585 | 2.337 | 2.337 | 0.273 | 0.273 | 0.504 | 0.504 |
SG&A
| 26.511 | 13.064 | 6.205 | 13.82 | 6.733 | 8.767 | 4.238 | 2.348 | 1.165 | 2.504 | 0.906 | 3.688 | 1.843 | 5.39 | 2.498 | 0.862 | 0.437 | 1.22 | 0.647 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 26.511 | 13.064 | 6.907 | 13.82 | 7.141 | 8.767 | 4.695 | 2.348 | 1.427 | 2.504 | 1.435 | 3.688 | 2.046 | 5.39 | 2.81 | 0.862 | 0.547 | 1.22 | 0.716 |
Operating Income
| 8.223 | 1.493 | 0.747 | 2.862 | 1.448 | 1.754 | 0.881 | 1.631 | 0.833 | 0.011 | 0.059 | 1.025 | 0.532 | 1.548 | 0.842 | 0.943 | 0.809 | 0.537 | 0.269 |
Operating Income Ratio
| 0.184 | 0.069 | 0.069 | 0.13 | 0.131 | 0.116 | 0.117 | 0.185 | 0.189 | 0.002 | 0.019 | 0.105 | 0.109 | 0.123 | 0.134 | 0.114 | 0.182 | 0.059 | 0.059 |
Total Other Income Expenses Net
| 0.21 | 0.033 | 0.016 | 0.261 | 0.113 | 0.025 | 0.008 | 0.033 | -0.001 | 0.104 | -0.001 | 0.03 | -0.004 | 0.134 | -0.001 | 0.674 | -0.001 | -0.004 | -0.002 |
Income Before Tax
| 8.433 | 1.526 | 0.763 | 3.122 | 1.561 | 1.778 | 0.889 | 1.664 | 0.832 | 0.116 | 0.058 | 1.055 | 0.527 | 1.682 | 0.841 | 1.617 | 0.808 | 0.533 | 0.267 |
Income Before Tax Ratio
| 0.188 | 0.07 | 0.07 | 0.142 | 0.142 | 0.118 | 0.118 | 0.189 | 0.189 | 0.019 | 0.019 | 0.108 | 0.108 | 0.134 | 0.134 | 0.196 | 0.182 | 0.059 | 0.059 |
Income Tax Expense
| 2.611 | 0.384 | 0.192 | 0.792 | 0.396 | 0.479 | 0.24 | 0.451 | 0.226 | 0.016 | 0.008 | 0.247 | 0.124 | 0.459 | 0.229 | 0.403 | 0.201 | 0.161 | 0.081 |
Net Income
| 5.822 | 1.142 | 0.571 | 2.331 | 1.165 | 1.299 | 0.65 | 1.213 | 0.606 | 0.1 | 0.05 | 0.808 | 0.404 | 1.223 | 0.611 | 1.214 | 0.607 | 0.372 | 0.186 |
Net Income Ratio
| 0.13 | 0.053 | 0.053 | 0.106 | 0.106 | 0.086 | 0.086 | 0.138 | 0.138 | 0.016 | 0.016 | 0.083 | 0.083 | 0.097 | 0.097 | 0.147 | 0.136 | 0.041 | 0.041 |
EPS
| 0.13 | 0.027 | 0.013 | 0.055 | 0.027 | 0.03 | 0.015 | 0.029 | 0.014 | 0.002 | 0.001 | 0.019 | 0.011 | 0.029 | 0.02 | 0.029 | 0 | 0.009 | 0 |
EPS Diluted
| 0.13 | 0.027 | 0.013 | 0.055 | 0.027 | 0.03 | 0.015 | 0.029 | 0.014 | 0.002 | 0.001 | 0.019 | 0.011 | 0.029 | 0.02 | 0.029 | 0 | 0.009 | 0 |
EBITDA
| 8.423 | 1.685 | 0.753 | 2.986 | 1.455 | 1.812 | 0.885 | 1.691 | 0.837 | 0.07 | 0.062 | 1.085 | 0.536 | 1.613 | 0.846 | 1.016 | 0.825 | 0.611 | 0.305 |
EBITDA Ratio
| 0.188 | 0.078 | 0.069 | 0.136 | 0.132 | 0.12 | 0.117 | 0.192 | 0.19 | 0.011 | 0.02 | 0.112 | 0.11 | 0.128 | 0.135 | 0.123 | 0.185 | 0.067 | 0.067 |